First Time Loading...

Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 73.9 USD 2.18% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one LGND stock under the Base Case scenario is 51.13 USD. Compared to the current market price of 73.9 USD, Ligand Pharmaceuticals Inc is Overvalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LGND Relative Value
Base Case
51.13 USD
Overvaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.9
P/S
P/S
Price to Sales
9.9
vs History
6
vs Industry
48
Median 3Y
6.1
Median 5Y
6.7
Industry
8.3
Forward
9.2
More Details
24.9
P/E
P/E
Price to Earnings
24.9
vs History
34
vs Industry
7
Median 3Y
25.5
Median 5Y
2.2
Industry
26.8
Forward
16.1
More Details
26.2
P/OCF
P/OCF
Price to OCF
26.2
vs History
34
vs Industry
6
Median 3Y
11
Median 5Y
16.9
Industry
23.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
8
Median 3Y
-9.4
Median 5Y
-8.1
Industry
21.4
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
30
vs Industry
48
Median 3Y
1.8
Median 5Y
1.6
Industry
2.6
More Details
8.6
EV/S
EV/S
Enterprise Value to Sales
8.6
vs History
7
vs Industry
42
Median 3Y
5.7
Median 5Y
5.3
Industry
7.5
Forward
8
More Details
9.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.3
vs History
9
vs Industry
42
Median 3Y
7.4
Median 5Y
6.8
Industry
9.2
More Details
24.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
24.3
vs History
30
vs Industry
5
Median 3Y
13
Median 5Y
14.3
Industry
4.5
Forward
13
More Details
114.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
114.8
vs History
23
vs Industry
1
Median 3Y
29.2
Median 5Y
27
Industry
4.4
Forward
23.9
More Details
22.7
EV/OCF
EV/OCF
Enterprise Value to OCF
22.7
vs History
31
vs Industry
7
Median 3Y
9.6
Median 5Y
10.4
Industry
5.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
8
Median 3Y
9.5
Median 5Y
9.7
Industry
3.4
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
22
vs Industry
50
Median 3Y
1.7
Median 5Y
1.6
Industry
5
More Details

Multiples Across Competitors

LGND Competitors Multiples
Ligand Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Ligand Pharmaceuticals Inc
NASDAQ:LGND
1.3B USD 9.9 24.9 24.3 114.8
US
Abbvie Inc
NYSE:ABBV
289.2B USD 5.3 60 13 19.9
US
Amgen Inc
NASDAQ:AMGN
166.7B USD 5.9 24.8 17.9 26.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.7B USD 8 26.5 17.8 19.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.8 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
47.8B USD 7 -10.1 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.7B USD 3.3 27.1 13.9 17.4
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
LGND intrinsic value, competitors valuation, and company profile.
DCF Valuation
LGND stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LGND stock valuation using valuation multiples.
Wall Street Estimates
LGND price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LGND stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.